APP and Alzheimer disease: PLAU, on the other hand, was shown to be a risk factor in the development of late-onset AD as a result of its involvement in the conversion of plasminogen to plasmin—a contributor to the processing of APP by the urokinase-type plasminogen activator (Finckh et al., 2003).